Početna › Osteosarkom › Texas › Houston

Kliničke studije za Osteosarkom u gradu Houston, TX

7 studija za Osteosarkom traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

U tijeku regrutacijaFaza 3

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
UT MD Anderson Cancer Center, Houston

Do 50 godina · Oba spola · Ažurirano 25. kol 2026. · NCT05235165

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

U tijeku regrutacijaFaza 1/2

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

U tijeku regrutacijaFaza 1

Texas Children's Hospital, Houston

Od 1 do 24 godina · Oba spola · Ažurirano 21. srp 2026. · NCT07211737

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

U tijeku regrutacijaFaza 1

The University of Texas MD Anderson Cancer Center, Houston

Od 12 do 50 godina · Oba spola · Ažurirano 15. srp 2026. · NCT03093909

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

U tijeku regrutacijaOpažajna studija

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

Sve dobne skupine · Oba spola · Ažurirano 18. svi 2026. · NCT01790152

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

U tijeku regrutacijaFaza 2

M D Anderson Cancer Center, Houston

Od 12 godina i više · Oba spola · Ažurirano 17. tra 2026. · NCT05019703

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

U tijeku regrutacijaFaza 1

Texas Children's Hospital, Houston

Od 1 do 25 godina · Oba spola · Ažurirano 22. sij 2026. · NCT04995003

Studije za Osteosarkom u drugim gradovima

Ostale studije u gradu Houston

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.